SPN and B-cell non-Hodgkin lymphoma: Nevertheless, our previous data revealed that constitutively active CD30 signaling (LMP1/CD30 expression) in B cells favors the development of B cell lymphomas with a CD43+CD23low B cell phenotype [25].